Related references
Note: Only part of the references are listed.Short- and Long-Term Effects of Cannabis on Headache and Migraine
Carrie Cuttler et al.
JOURNAL OF PAIN (2020)
Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder
Reilly R. Kayser et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?
Reilly R. Kayser et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
A naturalistic examination of the perceived effects of cannabis on negative affect
Carrie Cuttler et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
Rosanna Smart et al.
ADDICTION (2017)
Symptoms of obsessive-compulsive disorder predict cannabis misuse
Alexander Spradlin et al.
ADDICTIVE BEHAVIORS (2017)
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Michelle Sexton et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say?
Clarissa W. Ong et al.
JOURNAL OF ANXIETY DISORDERS (2016)
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
Mirella Nardo et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2014)
Pharmacological Treatment of Obsessive-Compulsive Disorder
Christopher Pittenger et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2014)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Mental Health Symptoms and their Relationship to Cannabis Use in Adolescents Attending Residential Treatment
Lucy Albertella et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
Plinio C. Casarotto et al.
BEHAVIOURAL PHARMACOLOGY (2010)
THE LATENT STRUCTURE OF OBSESSIVE-COMPULSIVE SYMPTOMS: A TAXOMETRIC STUDY
Bunmi O. Olatunji et al.
DEPRESSION AND ANXIETY (2008)
Marijuana use motives and social anxiety among marijuana-using young adults
Julia D. Buckner et al.
ADDICTIVE BEHAVIORS (2007)
Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation
J Daumann et al.
PSYCHOPHARMACOLOGY (2004)
Validity of a single-item measure of stress symptoms
AL Elo et al.
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH (2003)
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder
E Hollander et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Share Paper
